Clinical Trial

Validation of NAD+ Measurements for Human Clinical Studies

Name: Validation of NAD+ Measurements for Human Clinical Studies — clinical trial record (NCT07416786)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine nicotinamide adenine dinucleotide (NAD) levels in healthy adult subjects before and after supplementing with over-the counter nicotinamide riboside (NR) using magnetic resonance spectroscopy (MRS).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-10.

Trial Details

NCT Number	NCT07416786
Lead Sponsor	University of Pennsylvania Collaborators: National Institute on Aging (NIA)
Conditions	Healthy Adults
Enrollment	48 participants
Start Date	2026-07-01
Primary Completion	2027-07-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-03